Module Overview: The CME focused on the latest advancements in glaucoma management, including emerging therapies, innovations, challenges, and best practices. Dr. Keith Barton shared his expertise, delving into the complexities of glaucoma treatment and surgery.
Module 1 : Glaucoma 360: Emerging Therapies and Surgical Solutions" by Dr. Keith Barton, Consultant Ophthalmologist at Moorfields Eye Hospital, London, United Kingdom. Key Topics Discussed:
Innovation in Glaucoma Management:
Advancements in drug delivery systems and technologies aimed at improving glaucoma management outcomes.
Exploration of future surgical techniques with the potential to prevent glaucoma progression through less invasive procedures.
Modern Surgical Techniques:
The evolution of trabeculectomy, emphasizes how modern procedures differ from early methods.
Comparative analysis of trabeculectomy vs. Canal MIGS (Minimally Invasive Glaucoma Surgery), focusing on intraocular pressure (IOP) outcomes.
Updates on the International Glaucoma Surgery Registry and its role in refining surgical practices.
The evolution of minimally invasive bleb surgery, with a focus on subconjunctival MIGS.
Minimally Invasive Glaucoma Surgery (MIGS)
The shift towards subconjunctival MIGS and its role in improving surgical success.
The ongoing evolution of minimally invasive bleb surgery, including case studies.
First-in-human trials for glaucoma drainage devices and laser titration techniques.
Case Studies and Best Practices:
Real-world insights into the management of complex glaucoma cases.
Key principles established by Molteno for tube implants, including:
Permanent sclerostomy to ensure consistent drainage.
Equatorial drainage to leverage fibroblast activity.
Plate design to prevent external obstruction and optimize bleb surface area.
Future Innovations in Glaucoma Surgery:
Analyzing MIGS Studies:
Technological and Pharmacological Advances:
Panel Discussion: Dr. Parikh led a lively panel discussion with experts Dr. Chandrima Paul, Dr. Murali Ariga, Dr. Devindra Sood, and Dr. Sathyan Parthasarathi. They shared their real-world experiences and strategies in managing glaucoma, addressing key topics such as:
New developments in IOP measurement.
The role of virtual perimetry and triple combination therapies.
The potential of preservative-free technologies and nanotechnology in glaucoma treatment.
The use of gene therapy and its future role in clinical practice.
Insights from the LIGHT trial and the best MIGS options for IOP reduction.
Closing Remarks: Dr. Zenifer, Senior Manager, Medical Affairs at Viatris, delivered the closing note and vote of thanks, expressing appreciation for the participants' engagement and the valuable contributions of the speakers.
Conclusion: The CME provided participants with an in-depth understanding of current and future trends in glaucoma management. The discussions underscored the importance of staying updated with emerging technologies, surgical advancements, and evidence-based best practices.
We wish you a great learning experience!
Special thanks to Viatris for supporting this insightful event.
|
Sr. No
|
Topic
|
Faculty
|
Time Duration
|
|
1.
|
Welcome and introduction
|
Viatris Medical
|
5 mins
|
|
2.
|
Context setting
|
Moderator- Dr. Rajul Parikh
|
5 min
|
|
3.
|
Glaucoma 360: Emerging Therapies and Surgical Solutions"
|
International speaker -Dr. Keith Barton
|
40 mins
|
|
4
|
Panel discussion
|
Panelists-
Dr. Chandrima Paul
Dr Murali Ariga
Dr. Devindra Sood
Dr. Sathyan Parthasarathi
|
45 min
|
|
5
|
Closing remark & Vote of thanks
|
Viatris Medical
|
5 min
|
- Ophthalmologist
- Glaucoma specialist
